the determination [14] . W e have demonstrated that this probe lacks specificity and that the results o f such studies should be interpretated with great caution [15] . Analysis of GSH levels using validated high-performance liquid chromatography (HPLC) methods did not confirm the presence of decreased intracellular GSH levels [6, 16, 17] . On the contrary, Aukrust et ah [17] as w ell as our own group [6] showed significantly enhanced concentrations of both oxidized and total GSH in C D 4+ lymphocytes but not in other cell subsets. This indicates that the GSH redox potential is disturbed in C D 4+ T lym phocytes from HIV-infected patients, a finding consistent with enhanced oxidative stress and possibly important for the pathogen esis o f HIV infection. Aukrust et al. [17] also measured GSH and cysteine in plasma, but in this compartment the total and oxidized concentrations of these thiols were both reduced. Also, protein-bound cysteine was decreased in plasma from HIV-infected patients, and it seem s therefore that HIV infection is associated with low disul phide formation in plasma. Thus, the pro-oxidant status is limited to C D 4+ T lym phocytes and is not present in plasma. The same authors also report elevated plasma concentrations of reduced hom ocysteine in HIV infec tion [18] , and they argue that reduced hom ocysteine enhances free radical formation and stimulates HIV replication through NF-kappa B activation.
In a paper in this issue [19] , as w ell as in an earlier report [20] , plasma thiol levels in CVI patients are presented. Common variable im m unodeficiency is a heterogeneous group o f B -cell deficiency syndromes characterized by defective antibody production, and many patients also show som e abnormality in T-cell function. Patients with this disorder are often afflicted by recurrent bacterial infections, gastrointestinal diseases including malabsorption and lym phoid hyperplasia, autoimmune diseases and increased incidences o f lym phoid and gastrointestinal malignancies; however, they do not have an excess risk for cardiovascular diseases [21] . A subgroup of CVI patients is characterized by persistent immune activation in vivo. In this issue it is reported that, especially in this group, high plasma levels o f reduced hom ocysteine are significantly correlated with increased concentrations o f a product o f lipid per oxidation (high plasma m alonaldehyde) and low plasma levels of vitamin E [19] . It is concluded that elevated plasma levels o f reduced hom ocysteine are a marker o f enhanced oxidative stress.
It should first be questioned whether enhanced oxida tive stress was demonstrated in these patients. Anti oxidants appear to be indicators of the susceptibility of a subject to reactive oxygen species, reflecting the risk rather than the actual level of free radical damage. By assaying antioxidants such as vitamin E and carotene, it is difficult to discern cause and consequence of an observed effect [22] . Most pronounced effects have been observed in CVI patients with persistent immune activation, and these patients are characterized by low CD4 cell counts and the occurrence of splenomegaly and nodular intestinal lymphoid hyperplasia [23] . However, especially in these patients, gastrointestinal problems may arise and the absence of diarrhoea or hypoalbuminaemia does not exclude vitamin deficiency due to mal absorption. In animal experiments, food elements were found to be an important factor for the excretion of malonaldehyde; various fatty acids induced marked changes and vitamin E depletion or iron supplementation greatly increased malonaldehyde levels [24] .
Free radical damage can indeed be analysed by moni toring products of lipid peroxidation and shifts in redox status. Lipid peroxidation was assessed by measurement of plasma malonaldehyde concentration; however» this has important limitations, and many alternative para meters are available for this purpose [22] . Thiols other than homocysteine were measured in these patients, but the results, which are not in agreement with previous theories regarding enhanced oxidative stress, are not discussed. In previous reports it was found that elevated levels of reduced homocysteine were associated with a decrease in cysteine levels [25] , and the role of scavenger in a pro-oxidant state was therefore attributed to cysteine. However, in the present study no abnormality of cysteine was found. Enhanced levels of reduced plasma homo cysteine have been found in HIV-infected as well as CVI patients, but without a significant reduction in plasma levels of oxidized thiols such as GSH [20] or cysteine [19] , as would be expected in the case of a shift in redox status. In addition, homocysteine is supposed to cause endothelial damage through free radical damage; is it therefore not peculiar that no cardiovascular diseases are reported in these patients?
Overall, it can be concluded that some immunodefi ciency states are accompanied by metabolic changes, but the question remains whether these metabolic changes are simply manifestations of the damage that is caused by long-term immunodeficiency or whether these changes also compromise immune function.
